Silence Therapeutics (SLN) Research & Development: 2018-2024
Historic Research & Development for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to $67.9 million.
- Silence Therapeutics' Research & Development rose 1.91% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.7 million, marking a year-over-year increase of 126.21%. This contributed to the annual value of $67.9 million for FY2024, which is 19.22% up from last year.
- Per Silence Therapeutics' latest filing, its Research & Development stood at $67.9 million for FY2024, which was up 19.22% from $56.9 million recorded in FY2023.
- In the past 5 years, Silence Therapeutics' Research & Development registered a high of $67.9 million during FY2024, and its lowest value of $26.0 million during FY2020.
- Over the past 3 years, Silence Therapeutics' median Research & Development value was $56.9 million (recorded in 2023), while the average stood at $56.1 million.
- Per our database at Business Quant, Silence Therapeutics' Research & Development soared by 63.11% in 2021 and then fell by 2.88% in 2022.
- Over the past 5 years, Silence Therapeutics' Research & Development (MRY) stood at $26.0 million in 2020, then surged by 63.11% to $42.3 million in 2021, then increased by 2.88% to $43.5 million in 2022, then skyrocketed by 30.74% to $56.9 million in 2023, then rose by 19.22% to $67.9 million in 2024.
- Its Research & Development stands at $67.9 million for FY2024, versus $56.9 million for FY2023 and $43.5 million for FY2022.